1. Medicines and Risk/Benefit Decisions (Centre for Medicines Research Workshop Proceeding);Walker,1987
2. Benefit-Risk Balance for Marketed Drugs: Evaluating Safety Signals,1998
3. Wen S. Current European perspective in structured benefit-risk assessment. Presented at: Joint Statistical Meeting, August 5, 2013, Montreal, Canada.
4. The PhRMA Benefit-Risk Action Team. The PhRMA BRAT Framework for Benefit-Risk Assessment: User’s Guide to the Process. 2011. Available from: http://www.cirs-brat.org/. [Accessed June 26, 2014]
5. Application of the Benefit-Risk Action Team (BRAT) framework in pharmaceutical R&D: results from a pilot program;Noel;Drug Inf J,2012